Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (7,206,535)	$ (4,058,216)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	19,270	19,157
Stock-based compensation	3,767,674	415,172
Changes in operating assets and liabilities:
Accounts receivable	(23,461)	6,131
Insurance deposit	(1,000,000)
Other current assets	(235,287)	17,637
Accounts payable	1,808,861	646,484
Accrued liabilities	(3,532,625)	(18,914)
Insurance reserve	(365,905)	120,365
Deferred revenues	(16,003)	(10,564)
Net cash used in operating activities	(6,784,011)	(2,862,748)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock	29,727,500
Offering costs	(1,680,284)
Proceeds from exercise of warrants	64,540
Proceeds from exercise of stock options		28,575
Net cash provided by financing activities	28,111,756	28,575
Increase (Decrease) in cash, cash equivalents and restricted cash	21,327,745	(2,834,173)
Cash, cash equivalents and restricted cash - beginning of period	4,923,515	10,657,140
Cash, cash equivalents and restricted cash - end of period	26,251,260	7,822,967
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets
Total cash, and cash equivalents and restricted cash to the consolidated balance sheets	26,251,260	7,822,967
Supplemental disclosures of cash flow information:
Cash paid for interest		19
Cash paid for income taxes
Non-cash investing and financing activities:
Offering costs within accounts payable	446,021
Reclass of prior year offering costs	$ 33,164